Cryoglobulinemic vasculitis (CV)
Clinical trials for Cryoglobulinemic vasculitis (CV) explained in plain language.
Never miss a new study
Get alerted when new Cryoglobulinemic vasculitis (CV) trials appear
Sign up with your email to follow new studies for Cryoglobulinemic vasculitis (CV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare vasculitis: obinutuzumab steps in where rituximab fails
Disease control Recruiting nowThis phase 2 trial tests obinutuzumab, a drug similar to rituximab but possibly stronger, in 30 adults with active cryoglobulinemic vasculitis who did not improve or could not tolerate rituximab. The goal is to see if obinutuzumab can bring the disease under control and allow pat…
Matched conditions: CRYOGLOBULINEMIC VASCULITIS (CV)
Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Skin biopsies shed light on rare blood vessel disease
Knowledge-focused Recruiting nowThis study looks at skin samples from 50 people with different types of vasculitis, a condition where blood vessels become inflamed. Researchers want to understand how the disease affects the skin at a molecular level. Participants must have an active skin rash related to their v…
Matched conditions: CRYOGLOBULINEMIC VASCULITIS (CV)
Sponsor: Peter Merkel • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC